Obstructive Sleep Apnea Clinical Trial
Official title:
Sex Differences in Neurocirculatory Control With Obstructive Sleep Apnea
Verified date | June 2024 |
Source | Mayo Clinic |
Contact | Joshua Bock, PhD |
Phone | (507) 422-0768 |
Bock.Joshua[@]mayo.edu | |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The purpose of this study is to investigate potential sex differences in neurocirculatory control of blood pressure in patients with untreated obstructive sleep apnea (OSA).
Status | Recruiting |
Enrollment | 60 |
Est. completion date | March 2027 |
Est. primary completion date | March 2027 |
Accepts healthy volunteers | |
Gender | All |
Age group | 20 Years to 70 Years |
Eligibility | Inclusion Criteria: - 20-70 years of age Exclusion Criteria: - Coronary artery disease - Heart failure - Pregnancy - COPD - Diabetes - CKD - Sleep disorders other than OSA - Shift workers - Individuals who typically go to sleep after midnight - Individuals who traveled across =2 time zones within one week of study visits - BMI =40.0kg/m2 - Use of nicotine-containing products within the two years preceding study visits - Use of allopurinol, proton pump inhibitors, or other medications/supplements which interfere with outcome measures |
Country | Name | City | State |
---|---|---|---|
United States | Mayo Clinic in Rochester | Rochester | Minnesota |
Lead Sponsor | Collaborator |
---|---|
Mayo Clinic | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Cerebral autoregulation | Measured by transcranial doppler ultrasound (cm/sec). | Baseline | |
Other | Sympathetic action potentials per burst | Measured by Microneurography reported as action potentials per burst (reflecting firing rate). | Baseline | |
Other | Sympathetic action potential clusters per burst | Measured by Microneurography reported as clusters per burst (reflecting recruitment of latent subpopulations). | Baseline | |
Other | Sympathetic action potential conduction latency of each cluster | Measured by Microneurography reported as conduction latency of each cluster (reflecting synaptic delays and verifying larger amplitude clusters as new populations). | Baseline | |
Other | Immune function | Immune function will be measured as percent of parent cell population. | Baseline | |
Other | Urinary Extracellular Vesicle Presence and Content | Number of extracellular vesicles present in a 24 hour urine collection and the contents being carried by those vesicles. | Baseline | |
Other | Plasma Extracellular Vesicle Presence and Content | Number of extracellular vesicles present in blood plasma sample and the contents being carried by those vesicles. | Baseline | |
Primary | Blood pressure | Measured in millimeters of mercury (mmHg). | Baseline | |
Primary | Arterial stiffness | Measured by applanation tonometry reported as aortic pulse wave velocity (m/sec) | Baseline | |
Primary | Endothelial function | Ultrasound assessment of flow-mediated vasodilation of the brachial artery. Brachial artery diameter and blood velocity will be measured after deflation to measure endothelial function. | Baseline | |
Secondary | Sympathetic nerve burst frequency | Measured by Microneurography reported as number of nerve bursts per minute (burst/min) | Baseline | |
Secondary | Sympathetic nerve burst incidence | Measured by Microneurography reported as number of nerve burst per 100 heart beats (burst/100 heart beats) | Baseline | |
Secondary | Sympathetic nerve burst amplitude (AU) | Measured by Microneurography reported in arbitrary units (AU) | Baseline | |
Secondary | Total muscle sympathetic nerve activity (MSNA) | Measured by Microneurography reported burst arbitrary units per minute (AU/min) | Baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05857384 -
Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs
|
Phase 1 | |
Recruiting |
NCT04547543 -
Follow-up of Apneic Patients by Visio-consultation
|
N/A | |
Recruiting |
NCT05371509 -
Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study
|
N/A | |
Completed |
NCT02515357 -
Mediterranean Diet/Lifestyle Intervention in Obstructive Sleep Apnea
|
N/A | |
Completed |
NCT05582070 -
Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction
|
N/A | |
Active, not recruiting |
NCT03189173 -
Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea
|
Phase 2 | |
Completed |
NCT04084899 -
The Effect of CPAP on Lung Hyperinflation in Patients With OSA
|
||
Completed |
NCT03032029 -
Registry on the Treatment of Central and Complex Sleep-Disordered Breathing With Adaptive Servo-Ventilation
|
||
Recruiting |
NCT04028011 -
Clinical Evaluation of a Wearable Technology for the Diagnosis of Sleep Apnoea
|
||
Recruiting |
NCT06047353 -
Community Health Advocates for Motivating PAP Use in Our Neighborhoods.
|
N/A | |
Completed |
NCT05253963 -
Acute Effect of CPAP on Weight in Patients With Obstructive Sleep Apnea
|
N/A | |
Recruiting |
NCT06029959 -
Stroke and CPAP Outcome Study 3
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Completed |
NCT03589417 -
Postural Stability, Balance and Fall Risk in Patients With Obstructive Sleep Apnea
|
||
Recruiting |
NCT04335994 -
ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing
|
N/A | |
Withdrawn |
NCT04063436 -
Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea
|
N/A | |
Recruiting |
NCT05385302 -
Sociological Determinants of Positive Airway Pressure Adherence in OSA Patients
|
||
Recruiting |
NCT04572269 -
Metabolomics of Obstructive Sleep Apnea
|
||
Not yet recruiting |
NCT06467682 -
12-week Tele-exercise Program in Patients With OSA
|
N/A | |
Withdrawn |
NCT04011358 -
Retinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study
|
N/A |